ID   LH86
AC   CVCL_8889
SY   LH-86
DR   BTO; BTO:0004142
DR   Wikidata; Q54902469
RX   Patent=US8017391;
RX   PubMed=17983809;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7435.
CC   Doubling time: ~42 hours (Patent=US8017391).
CC   HLA typing: A*24,25; B*07 (Patent=US8017391).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
RX   Patent=US8017391;
RA   Liu C., Hemming A., Zhu H.-Z.;
RT   "Human liver cancer cell line.";
RL   Patent number US8017391, 13-Sep-2011.
//
RX   PubMed=17983809; DOI=10.1053/j.gastro.2007.09.017;
RA   Zhu H.-Z., Dong H.-J., Eksioglu E.A., Hemming A., Cao M.-D.,
RA   Crawford J.M., Nelson D.R., Liu C.;
RT   "Hepatitis C virus triggers apoptosis of a newly developed hepatoma
RT   cell line through antiviral defense system.";
RL   Gastroenterology 133:1649-1659(2007).
//